A cellular calculus for signal integration by T cells

During an immune response numerous receptor-mediated signals delivered to T cells direct their proliferation, survival and differentiation. Here, we describe a quantitative model and in vitro methods for assessing the “calculus” used by T cells to process these multiple signals. The model reveals how T cells convert independently received signals into linear additive effects on division times which, in turn, amplify T cell number exponentially. These results explain why so many ligands can each appear obligatory for T cell activation and argue for a re-examination of the two-signal theory as the basis for decisions between tolerance and activation.

[1]  Antonio Lanzavecchia,et al.  T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds , 1996, Science.

[2]  P. Hodgkin,et al.  Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Linsley,et al.  CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production , 1994, The Journal of experimental medicine.

[4]  J. Allison,et al.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones , 1992, Nature.

[5]  R. Schwartz,et al.  Models of T Cell Anergy: Is There a Common Molecular Mechanism? , 1996 .

[6]  Melvin Cohn,et al.  A Theory of Self-Nonself Discrimination , 1970, Science.

[7]  T. Mak,et al.  Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. , 1997, Immunity.

[8]  Dan R. Littman,et al.  Signal transduction by lymphocyte antigen receptors , 1994, Cell.

[9]  K. Lafferty,et al.  A new analysis of allogeneic interactions. , 1975, The Australian journal of experimental biology and medical science.

[10]  P. Linsley,et al.  CTLA-4 can function as a negative regulator of T cell activation. , 1994, Immunity.

[11]  Susanne A. Fischer,et al.  Interleukin‐12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells , 1993, European journal of immunology.

[12]  P. Hodgkin,et al.  Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester , 1999, Immunology and cell biology.

[13]  P. Krammer,et al.  Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) , 1995, Nature.

[14]  J. Sprent,et al.  Strong TCR ligation without costimulation causes rapid onset of Fas-dependent apoptosis of naive murine CD4+ T cells. , 1999, Journal of immunology.

[15]  L. Davis,et al.  Promotion of human T lymphocyte proliferation by IL-4. , 1989, Journal of immunology.

[16]  W. J. Spillman.  COLOR INHERITANCE IN MAMMALS. , 1907, Science.

[17]  R. Seder.  Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, The Journal of allergy and clinical immunology.

[18]  C. Thompson,et al.  CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.

[19]  D. Loh,et al.  Receptor-stimulated death pathway is opened by antigen in mature T cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Lenardo.  Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. , 1991, Nature.

[21]  R. Fernandez-Botran,et al.  Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells , 1988, The Journal of experimental medicine.

[22]  Seamus J. Martin,et al.  Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas , 1995, Nature.

[23]  T. Idziorek,et al.  T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)- mediated apoptosis of CD4+ T cells from human immunodeficiency virus- infected persons , 1995, The Journal of experimental medicine.

[24]  P. Marrack,et al.  Interleukin 4 (IL-4) or IL-7 Prevents the Death of Resting T Cells: Stat6 Is Probably Not Required for the Effect of IL-4 , 1997, The Journal of experimental medicine.

[25]  D. Cantrell,et al.  The interleukin-2 T-cell system: a new cell growth model. , 1984, Science.

[26]  A. Lanzavecchia,et al.  The duration of antigenic stimulation determines the fate of naive and effector T cells. , 1998, Immunity.

[27]  G. Trinchieri.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.

[28]  C. Thompson,et al.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.

[29]  J. Allison,et al.  CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation , 1995, The Journal of experimental medicine.

[30]  J. Allison,et al.  CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells , 1996, The Journal of experimental medicine.

[31]  K P Lee,et al.  Differential T cell costimulatory requirements in CD28-deficient mice. , 1993, Science.

[32]  P. Bretscher,et al.  A two-step, two-signal model for the primary activation of precursor helper T cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Flavell,et al.  The Role of CD40 Ligand in Costimulation and T‐Cell Activation , 1996, Immunological reviews.

[34]  J. Bluestone,et al.  Identification of a monoclonal antibody specific for a murine T3 polypeptide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Bluestone,et al.  The Complexities of T‐Cell Co‐stimulation: CD28 and Beyond , 1996, Immunological reviews.

[36]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[37]  J. Allison,et al.  Co-stimulation in T cell responses. , 1997, Current opinion in immunology.

[38]  C. Janeway,et al.  Signals and signs for lymphocyte responses , 1994, Cell.

[39]  A. Sette,et al.  Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo , 1995, The Journal of experimental medicine.

[40]  A. Weinberg,et al.  IL-4 directs the development of Th2-like helper effectors. , 1990, Journal of immunology.

[41]  M. Brown,et al.  IL-4/B cell stimulatory factor 1 stimulates T cell growth by an IL-2-independent mechanism. , 1988, Journal of immunology.

[42]  W. Paul,et al.  Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, Annual review of immunology.

[43]  Kendall A. Smith,et al.  Interleukin-2: inception, impact, and implications. , 1988, Science.

[44]  J. Bluestone,et al.  CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. , 1996, Journal of immunology.

[45]  G. Crabtree,et al.  Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. , 1991, Science.

[46]  R. Schwartz,et al.  Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. , 1989, Annual review of immunology.

[47]  A. B. Lyons,et al.  Determination of lymphocyte division by flow cytometry. , 1994, Journal of immunological methods.

[48]  K. Lafferty,et al.  Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. , 1983, Annual review of immunology.

[49]  J. Bluestone,et al.  Absence of B7-dependent responses in CD28-deficient mice. , 1994, Immunity.